Skip to main content
Premium Trial:

Request an Annual Quote

Epigenomics and Biopsytec Cross-License Genetic Technologies

SAN FRANCISCO, April 25 - German biotechs Epigenomics and Biopsytec said on Thursday that they have cross-licensed each other's genetic analysis technologies.


Epigenomics has exclusive rights to use Biopsytec's Identification of Linkage Disequilibrium technology in pharmaceutical research and diagnostics. Biopsytec has exclusive rights to use Epigenomics' DNA-methylation technologies in agricultural research.


Financial terms of the agreement were not disclosed.


Epigenomics said it would apply ILD technology to discovery of new drug targets and the identification of the genetic causes of adverse side-effects in patient populations involved in clinical trials.


Biopsytec, an agricultural genetics company, plans to use the DNA-methylation technology to turn on and off genes to improve the results of animal and plant breeding.


"With Biopsytec being an agricultural specialist and Epigenomics focusing exclusively on human health care, this agreement is a perfect fit," Arno Heuermann, CEO of Biopsytec, said in a statement. "Each company provides the other with the complementary technologies that enable a comprehensive and unique approach to the two very different markets."


Both companies are based in Berlin.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.